PATHOLOGIEDATENERFASSUNG

European patent · EP3491558 · In force

Register entry

Publication number
EP3491558
Application number
EP17749337
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Jul 28, 2017
Published
Jun 5, 2019
Granted
Oct 15, 2025
Protection ends at the latest
Jul 27, 2037
Next annual fee due
Jul 31, 2026
IPC classes
G16H 30/40 (2018.01)
G16H 30/20 (2018.01)
G16H 10/40 (2018.01)
G02B 21/36 (2006.01)
G02B 27/00 (2006.01)
Priority
US 201615225247 01.08.2016
PCT application
PCT/US2017/044541 28.07.2017
PCT publication
WO2018/026666 08.02.2018
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Aug 26, 2026

    Change

    Published in Swissreg on 26.08.2026

  2. Apr 23, 2026

    Owner

    Owner
    Verily Life Sciences LLC, 2999 Olympus Blvd, 10th Floor / Ste 1000, Dallas, TX 75019, USA → Verily Health Inc., 2999 Olympus Blvd, 10th Floor, Ste 1000, Dallas, Texas 75019, USA

    Published in Swissreg on 23.04.2026

  3. Oct 15, 2025

    Granted

    Specification status
    Non-published patent application → Granted patent
    Status of protective title
    Initiated → Active

    Published in Swissreg on 15.10.2025

Parties

Holder

Verily Health Inc.

2999 Olympus Blvd 10th Floor, Ste 1000, Dallas, Texas 75019, US

Inventor

BARRAL, Joëlle K.

Mountain View, California 94043, US

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.